EUVIMEDEUVIMED entdecken
Open Access

Understanding Reasons for Oral Anticoagulation Nonprescription in Atrial Fibrillation Using Large Language Models

Sulaiman Somani iD, Dale Daniel Kim iD, Eduardo Perez-Guerrero iD, Summer Ngo iD, Tina Seto iD, Sadeer Al-Kindi iD, Tina Hernandez-Boussard iD, Fatima Rodriguez iD

Journal of the American Heart Association · 2025-04 · 14 (7)

DOI: 10.1161/jaha.124.040419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025-04. Verfasst von Sulaiman Somani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Stanford University Stanford CA USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Stroke, Nonprescription Drugs. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rates of oral anticoagulation (OAC) nonprescription in atrial fibrillation approach 50%. Understanding reasons for OAC nonprescription may reduce gaps in guideline‐recommended care. We aimed to identify reasons for OAC nonprescription from clinical notes using large language models.

Methods

We identified all patients and associated clinical notes in our health care system with a clinician‐billed visit for atrial fibrillation without another indication for OAC and stratified them on the basis of active OAC prescriptions. Three annotators labeled reasons for OAC nonprescription in clinical notes on 10% of all patients (“annotation set”). We engineered prompts for a generative large language model (Generative Pre‐trained Transformer 4) and trained a discriminative large language model (ClinicalBERT) to identify reasons for OAC nonprescription and selected the best‐performing model to predict reasons for the remaining 90% of patients (“inference set”).

Results

A total of 35 737 patients were identified, of which 7712 (21.6%) did not have active OAC prescriptions. A total of 910 notes across 771 patients were annotated. Generative Pre‐trained Transformer 4 outperformed ClinicalBERT (macro‐F1 score across all reasons of 0.79, compared with 0.69 for ClinicalBERT). Using Generative Pre‐trained Transformer 4 on the inference set, 61.1% of notes had documented reasons for OAC nonprescription, most commonly the alternative use of an antiplatelet agent (23.3%), therapeutic inertia (21.0%), and low burden of atrial fibrillation (17.1%).

Conclusions

This is the first study using large language models to extract documented reasons for OAC nonprescription from clinical notes in patients with atrial fibrillation and reveals guideline‐discordant practices and actionable insights for the development of health system interventions to reduce OAC nonprescription.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnticoagulantsStrokeNonprescription DrugsHumansAdministration, OralMaleFemaleAgedMiddle AgedElectronic Health RecordsAged, 80 and overRetrospective StudiesLarge Language Models

Stichwörter der Autor:innen

atrial fibrillationelectronic health recordlarge language modelsoral anticoagulationstroke

Substanzen

AnticoagulantsNonprescription Drugs

Autor:innen und Institutionen

  • Department of Medicine Stanford University Stanford CA USA.
  • School of Medicine Stanford University Stanford CA USA.
  • Division of Cardiovascular Medicine, Cardiovascular Institute, and the Center for Digital Health Stanford University Stanford CA USA.
  • Technology and Digital Solutions Stanford Health Care Stanford CA USA.
  • DeBakey Heart and Vascular Center Houston Methodist Houston TX USA.
  • Department of Biomedical Data Science Stanford University Stanford CA USA.

ORCID-Profile: Sulaiman Somani, Dale Daniel Kim, Eduardo Perez-Guerrero, Summer Ngo, Tina Seto, Sadeer Al-Kindi, Tina Hernandez-Boussard, Fatima Rodriguez

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Somani, S., Kim, D. D., Perez-Guerrero, E., Ngo, S., Seto, T., Al-Kindi, S., Hernandez-Boussard, T., & Rodriguez, F. (2025). Understanding Reasons for Oral Anticoagulation Nonprescription in Atrial Fibrillation Using Large Language Models. Journal of the American Heart Association, 14(7). https://doi.org/10.1161/jaha.124.040419

Vancouver

Somani S, Kim DD, Perez-Guerrero E, Ngo S, Seto T, Al-Kindi S, et al. Understanding Reasons for Oral Anticoagulation Nonprescription in Atrial Fibrillation Using Large Language Models. Journal of the American Heart Association. 2025;14(7). doi:10.1161/jaha.124.040419

BibTeX
@article{Somani2025,
  author = {Somani, Sulaiman and Kim, Dale Daniel and Perez-Guerrero, Eduardo and Ngo, Summer and Seto, Tina and Al-Kindi, Sadeer and Hernandez-Boussard, Tina and Rodriguez, Fatima},
  title = {Understanding Reasons for Oral Anticoagulation Nonprescription in Atrial Fibrillation Using Large Language Models},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {7},
  doi = {10.1161/jaha.124.040419}
}
Kostenlos starten →